[ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D005998:Glycine / Q000008:administration & dosage / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous; D013438:Sulfhydryl Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D013438:Sulfhydryl Compounds; D001379:Azathioprine; D005998:Glycine
L' -mercaptopropionilglicina (Thiola) nel trattamento delle epatiti croniche.